Korean Market
OWNR
Samjin Pharmaceutical
★

Samjin Pharmaceutical Executive Park Chang-ik Buys 2,000 Shares, Slight Stake Increase and Share Cancellation Positive

 
OWNR
Samjin Pharmaceutical
★

Samjin Pharma Major Shareholder Choe Seung-ju Reports Changes in Pledge Contracts, No Change in Stake or Voting Rights (Neutral)

 
EXCH
Samjin Pharmaceutical
★

Samjin Pharmaceutical Discloses Corporate Governance Report: Share Buyback of 580,000 Shares, Stable Dividend Policy, and Ongoing Governance Improvements

 
OWNR
Samjin Pharmaceutical
★★

Hana Pharm and related party drastically reduce stake in Samjin Pharmaceutical from 8.33% to 0.75%... On-market sale for simple investment purpose puts downward pressure on stock

 
OWNR
Samjin Pharmaceutical
★★

Hana Pharm reduces stake in Samjin Pharmaceutical from 8.33% to 1.22% (sells 995,198 shares on market)

 
OWNR
Samjin Pharmaceutical
★

Executive Sangjin Kim increases stake to 0.08% via open market purchase of 3,000 shares at KRW 17,869

 
OWNR
Samjin Pharmaceutical
★

Non-Registered Director Shin Seung-won Acquires 600 Common Shares via Open Market (0.00% Stake)

 
PERI
Samjin Pharmaceutical
★

Samjin Pharmaceutical Q1 2026: Sales -3.9%, Operating Profit -25.8%, R&D Investment Expands (12.24% of Sales)

 
EXCH
Samjin Pharmaceutical
★★

2025 Annual Individual Financial Results: Revenue Slightly Up (+0.3%) but Net Profit Plunges 39.5%